CRIS Current Research Information System

POTENA, LUCIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.890
AS - Asia 6.177
EU - Europa 4.684
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 352
AF - Africa 322
OC - Oceania 24
Totale 18.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.758
SG - Singapore 1.681
VN - Vietnam 1.651
CN - Cina 1.514
IT - Italia 1.234
GB - Regno Unito 826
DE - Germania 616
SE - Svezia 572
HK - Hong Kong 408
FR - Francia 277
BR - Brasile 264
IN - India 257
UA - Ucraina 237
RU - Federazione Russa 190
IE - Irlanda 167
NL - Olanda 160
KR - Corea 136
JP - Giappone 123
BD - Bangladesh 100
FI - Finlandia 98
ZA - Sudafrica 92
CA - Canada 80
TG - Togo 72
JO - Giordania 64
CI - Costa d'Avorio 63
BG - Bulgaria 59
EE - Estonia 49
AT - Austria 44
PH - Filippine 43
AR - Argentina 41
CH - Svizzera 38
TH - Thailandia 34
SC - Seychelles 32
NG - Nigeria 31
ES - Italia 23
BE - Belgio 22
TR - Turchia 22
AU - Australia 21
MX - Messico 21
ID - Indonesia 20
IQ - Iraq 19
IR - Iran 19
PL - Polonia 17
TW - Taiwan 16
PK - Pakistan 15
CO - Colombia 11
LT - Lituania 11
SA - Arabia Saudita 11
EC - Ecuador 10
GR - Grecia 10
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 7
MA - Marocco 7
PY - Paraguay 7
UY - Uruguay 7
CR - Costa Rica 6
DZ - Algeria 6
LB - Libano 6
PT - Portogallo 6
RO - Romania 6
TN - Tunisia 6
VE - Venezuela 6
AZ - Azerbaigian 5
CL - Cile 5
JM - Giamaica 5
PE - Perù 5
CZ - Repubblica Ceca 4
DK - Danimarca 4
EU - Europa 4
KE - Kenya 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
EG - Egitto 3
HU - Ungheria 3
MY - Malesia 3
NI - Nicaragua 3
PR - Porto Rico 3
SV - El Salvador 3
AM - Armenia 2
CY - Cipro 2
FJ - Figi 2
KG - Kirghizistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MC - Monaco 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 18.448
Salva come PNG Salva come JPEG
Città #
Singapore 1.195
Ashburn 776
Southend 682
San Jose 511
Fairfield 465
Chandler 413
Houston 410
Hong Kong 391
Ho Chi Minh City 386
Hanoi 366
Hefei 293
Santa Clara 272
Woodbridge 249
Wilmington 232
Seattle 222
Bologna 219
Beijing 214
Princeton 197
Boardman 175
Council Bluffs 172
Cambridge 171
Dublin 167
Jacksonville 154
Ann Arbor 136
New York 134
Los Angeles 128
Seoul 116
Milan 112
Lauterbourg 108
Tokyo 106
Bremen 85
Westminster 74
Helsinki 73
Lomé 72
Nanjing 70
Padova 70
Dong Ket 69
Dallas 68
Buffalo 65
Amman 64
Abidjan 63
Berlin 63
Munich 63
Da Nang 61
Turin 59
Haiphong 58
Rome 58
Sofia 58
Frankfurt am Main 50
Shenyang 44
São Paulo 44
Jinan 42
Mülheim 34
Medford 33
Shanghai 33
Bengaluru 32
Redmond 32
Saint Petersburg 32
Florence 31
Abeokuta 29
Changsha 29
Guangzhou 28
Hebei 28
Redondo Beach 28
Vienna 28
Johannesburg 25
Bern 24
Falkenstein 24
Hải Dương 24
San Diego 24
Toronto 24
Biên Hòa 23
London 23
Tianjin 22
Zhengzhou 22
Nanchang 21
Jiaxing 20
Atlanta 19
Orem 19
Phoenix 19
Brooklyn 18
Brussels 18
Turku 18
Chicago 17
Mahé 17
Montreal 16
The Dalles 16
Verona 16
Yubileyny 16
Amsterdam 15
Bangkok 15
Bắc Ninh 15
Des Moines 15
Nuremberg 15
Stockholm 15
Thái Nguyên 15
Can Tho 14
Dearborn 14
Ha Long 14
Warsaw 14
Totale 11.588
Salva come PNG Salva come JPEG
Nome #
L'inibitore endogeno della eNOS , la dimetil-arginina simmetrica (ADMA), è un nuovo fattore di rischio di vasculopatia coronarica post trapianto di cuore ed è infulenzato dalla terapia con sirolimus. 434
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. 372
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 335
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 274
Changes in exercise capacity induced by heart transplantation: prognostic and therapeutic implications. 252
Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes 246
Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle. 241
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies 230
Heart Transplant and Hepato-Renal Dysfunction: The Model of End-Stage Liver Disease Excluding International Normalized Ratio as a Predictor of Postoperative Outcomes 216
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 209
Le complicanze metaboliche post-trapianto di cuore ruolo dell'adiponectina ed associazione con la malattia coronarica del graft 208
Identification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD Scintigraphy 206
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis. 206
Age and heart transplantation: results from a heart failure management unit. 199
Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure. 196
Manifestations of health anxiety in patients with heart transplant 196
Diagnosi non invasiva di rigetto miocardico acuto: l'analisi armonica dell'ecg coadiuva la valutazione clinica 194
Impact of Predicted Heart Mass–Based Donor-Recipient Size Matching on Transplant Outcomes 192
Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease 188
Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes. 188
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. 186
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 186
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 186
Static and dynamic predictors of adverse events in patients with intermediate cardiopulmonary capacity referred for heart transplantation. 186
Relationship between psychiatric disorders and physical status during the course of a heart transplantation program: a prospective, longitudinal study. 184
Clinical presentations leading to arrhythmogenic left ventricular cardiomyopathy 182
Candidacy for heart transplantation in adult congenital heart disease patients: A cohort study 181
Prognostic stratification of women with chronic heart failure referred for heart transplantation: relevance of gender as compared with gender-related characteristics. 181
Impact of Pre-Transplant Pulmonary Hypertension Grading on Early- to Long-Term Hemodynamics, Right Venticular Graft Function and Survival After Heart Transplantation 181
Influence of the MELD-XI (Model of End-Stage Liver Disease Excluding INR) on Heart Transplant Outcomes 180
Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation 180
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 180
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 179
Comprehensive Non-invasive Versus Invasive Approach to Evaluate Cardiac Allograft Vasculopathy in Heart Transplantation: The CCTA-HTx Study 178
Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset 176
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 176
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 176
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 175
Qualità della vita e parametri clinico-strumentali nello scompenso cardiaco. 174
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 172
Nitrates and Angina: an insight into arterial and venular involvement in blood flow regulation. 171
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 171
Ruolo dell'NT-proBNP nella stratificazione prognostica dei pazienti con scompenso cardiaco cronico. 168
Il rallentamento del flusso di perfusione coronarica valutato con il TIMI frame count è in grado di predire la mortalità a lungo termine nei pazienti con trapianto di cuore 165
Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study. 164
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 163
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 163
Viral genome search in myocardium of patients with fulminant myocarditis 163
La progressione della coronarografia del graft è proporzionale alla severità dell'infezione da citomegalovirus nei pazienti con trapianto cardiaco. 162
Prophylaxis vs. Pre-Emptive Strategies in Preventing Cytomegalovirus-Dependent Cardiac Allograft Vasculopathy 162
Efficacia e sicurezza dell'ezetimibe in associazione con basse dosi di simvastatina per il trattamento dell'iperlipidemia post-trapianto cardiaco 162
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 162
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort 161
Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue 161
Reproducibility of IVUS Measurements in Heart Transplant Recipients: Increased Quality of Data by Using Dedicated Software for Image Analysis 159
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling. 158
Prolactin Inhibition to Treat Postpartum Arrhythmic Storm 157
Predicting Right Ventricular Failure in the Current Continuous Flow Left Ventricular Assist Device Era 157
Long-term immune response after SARS-CoV2 vaccination in solid organ transplant recipients 155
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 155
PRE-TRANSPLANT NON-CYTOTOXIC ANTI-HLA ANTIBODIES PREDICT MULTIPLE ADVERSE EVENTS AFTER HEART TRANSPLANTATION 154
Homocysteine-lowering therapy and early progression of transplant vasculopathy: a prospective, randomized, IVUS-based study. 154
Pre-Transplant Non-Cytotoxic Anti-HLA Antibodies Predict Multiple Adverse Events after Heart Transplantation 154
Correlazione tra metodi semiquantitativi e quantitativi nella valutazione dell'insufficienza mitralica organica ed associazione con test da sforzo cardiopolmonare e pro-BNP 153
L'inibitore endogeno della eNOS favorisce la progressione dell'infezione da cytoomegalovirus e del rigetto miocardico acuto nei pazienti con trapianto di cuore. 152
L'infezione da citomegalovirus e i parametri indicativi di insulino-resistenza influenzano in modo distinto e specifico le variazioni nella geometria coronarica nel primo anno dopo trapianto di cuore 151
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients? 149
Heart transplantation in hypertrophic cardiomyopathy. 148
Relevance of cardioverter defibrillators for the prevention of sudden cardiac death on the timing of heart transplantation. 148
Interplay between Pulmonary Hypertension and Donor-Recipient Matching in the Risk for Early Graft Failure after Heart Transplantation 147
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 146
Clinical profile and in-hospital outcome of patients supported by intra-aortic balloon pump in the clinical setting of cardiogenic shock 145
Prevalence of substance-related disorders in heart transplantation candidates 143
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians 143
Psychological predictors of mortality in heart transplanted patients: a prospective, 6-year follow-up study. 141
Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome 140
L'infezione subclinica da citomegalovirus modula l'infiammazione sistemica e il rimodellamento coronarico ad un anno dal trapianto. 140
SAFETY AND EFFICACY OF TWO TYPES OF INFLUENZA VACCINATION IN HEART TRANSPLANT RECIPIENTS: A PROSPECTIVE RANDOMISED CONTROLLED STUDY 140
Insufficienza mitralica organica: parametri ecocardiografici, funzionali e neuro-ormonali potenziali predittori di intervento chirurgico a breve termine 139
Effect of a Fourth Dose of mRNA Vaccine and of Immunosuppression in Preventing SARS-CoV-2 Breakthrough Infections in Heart Transplant Patients 138
Extracorporeal Membrane Oxygenation Support System as Bridge to Solution in Refractory Cardiogenic Shock 137
Impact of Current Donor Scores Calculation on Heart Transplantation Outcomes 137
Potential of medical treatment, device therapy, and conventional surgery in patients referred for heart transplantation. 134
Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis 132
Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions. 131
Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients. 131
Impact of prior sternotomy on survival and allograft function after heart transplantation: A single center matched analysis 130
Cytomegalovirus infectious burden is proportional to cardiac allograft vasculopathy in heart transplant recipients 129
Donor risk analysis and validation in heart transplants: A single-centre experience 129
Donor-derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report 129
Studio prospettico randomizzato sull'effetto della terapia con acido folico nella preenzione della malattia coronarica nel paziente trapiantato 124
CTA-Derived Pericoronary Fat Attenuation Index Predicts Allograft Rejection and Cardiovascular Events in Heart Transplant Recipients 122
Role of Donor-Recipient Match in Determining the Risk for Primary Graft Failure after Heart Transplantation 122
Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality = Sistemi di ossigenazione a membrana extracorporea come trattamento per lo shock cardiogeno refrattario nella popolazione adulta: strategie, risultati e predittori di mortalità 122
COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak 122
Long-term effect of folic Acid therapy in heart transplant recipients: follow-up analysis of a randomized study. 114
Update and review: state-of-the-art management of cytomegalovirus infection and disease following thoracic organ transplantation. 114
Evidence and current use of levosimendan in the treatment of heart failure: Filling the gap 112
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 110
Management of heart transplant candidates in the time of COVID-19 pandemic: Looking for answers 109
Totale 17.035
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.482
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.535 0 51 108 214 132 70 41 121 65 149 322 262
2022/20232.110 192 269 109 256 182 189 55 114 379 86 193 86
2023/2024739 39 104 41 77 30 174 41 57 34 59 27 56
2024/20252.788 161 414 214 200 393 152 153 120 36 193 177 575
2025/20266.899 681 651 530 480 728 302 637 313 1.477 556 294 250
2026/2027546 281 265 0 0 0 0 0 0 0 0 0 0
Totale 18.805